Bexion Pharmaceuticals
Bexion Pharmaceuticals is a mid-stage clinical company developing life-changing treatments in Oncology and CNS.
27 employees · est. 2006 · Covington, United States
Nereus Pharmaceuticals
Pioneering marine microbiology to develop advanced treatments for cancer, infections, and inflammation since 1998.
est. 1998
Nereus Pharmaceuticals is the older company (2006 vs 1998).
Side-by-Side Comparison
| Metric | Bexion Pharmaceuticals | Nereus Pharmaceuticals |
|---|---|---|
| Founded | ||
| Founded | 2006 | 1998 older |
| Headquarters | ||
| Headquarters | Covington, United States | Not tracked yet |
| Employees | ||
| Employees | 27 | Not tracked yet |
| Industry | ||
| Industry | Biopharma, Biotechnology, Life Sciences | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Unknown | Series E |
| Total Funding | ||
| Total Funding | $18.00M | $139.80M |
| Funding Rounds | ||
| Funding Rounds | 4 | 5 |
| Services | ||
| Services | Development of cancer therapies, Clinical-stage drug development, Phase 1b/2a clinical trials, Biologic therapy research | Not tracked yet |
| Target Customers | ||
| Target Customers | Cancer patients, Oncologists, Clinical researchers, Biopharmaceutical investors | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Oncology, CNS (Central Nervous System), S1P Modulator, BXQ-350, Tumor Targeting, Phosphatidylserine Patches, Acid Sphingomyelinase Activation, Ceramide Generation, Caspase Elevation, Biopharmaceutical, Clinical Development, Novel Mechanism Of Action, Tumor Neovasculature, Apoptosis Induction | Marine Microbiology, Therapeutics, Oncology, Infectious Diseases, Inflammation, Drug Discovery, NPI-2358, Tumor Vascular Disrupting Agent, NPI-0052, Proteasome Inhibitor, Solid Tumors, Lymphomas, Multiple Myeloma, San Diego, Biopharmaceutical |
| Website | ||
| Website | bexionpharma.com | nereuspharm.com |
About Bexion Pharmaceuticals
Bexion Pharmaceuticals, founded in 2006, is a United States-based company operating at the forefront of the Biopharma, Biotechnology, Life Sciences, and Pharmaceutical industries. The company has carved out a niche in developing transformative treatments within the oncology and central nervous syste...
About Nereus Pharmaceuticals
Nereus Pharmaceuticals, Inc. is a biotechnology company that has been pioneering marine microbiology to develop advanced treatments for cancer, infections, and inflammation since 1998. The company focuses on discovering and developing therapeutics for oncology, infectious diseases, and inflammation,...
We will tell you when either one moves
BounceWatch watches Bexion Pharmaceuticals and Nereus Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Bexion Pharmaceuticals and Nereus Pharmaceuticals — by email.
Frequently Asked Questions
Compare Bexion Pharmaceuticals with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Bexion Pharmaceuticals on 11 Mar 2026, and Nereus Pharmaceuticals on 26 Jul 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
